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The incidence of cervical cancer in pregnancy is 1–10/10,000
(Duggan et al., 1993). The standard treatment for early-stage cervical
cancer is radical hysterectomy and/or chemoradiation. Radical vaginal
trachelectomy is an attractive alternative in women who wish to pre-
serve their fertility (Shepherd and Milliken, 2008). However, a young
woman diagnosed with early-stage cervical cancer while pregnant is a
clinical dilemma. The maternal risks need to be balanced against the
risks to the foetus. Treatment options would include: termination of
pregnancy followed by standard treatment; cancers that are diagnosed
after 24 gestationalweeks can have their treatment deferred until deliv-
ery is feasible i.e. up to approximately 32–34 weeks; neoadjuvant che-
motherapy whilst pregnant with in-utero foetal exposure to toxicity;
and radical vaginal trachelectomy.
This is the seventh case report of radical vaginal trachelectomy
performed during the second trimester in a youngwomanwith an inva-
sive cervical cancer (Ferriaoli et al., 2012; Iwami et al., 2011; Siuotas
et al., 2011; Van De Nieuwenhof et al., 2008) (see Table 1). The purpose
of this case report is to continue to highlight to the gynaecological onco-
logical community the clinical challenges encountered in youngwomen
diagnosed with cervical cancer whilst pregnant.⁎ Corresponding author at: Department of Gynaecological, Oncology, The RoyalMarsden
NHS Foundation Trust, London SW3 6JJ, UK. Fax: +44 20 7811 8104.
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A 27 year old nulliparous woman presented in November 2008 with
a 2 month history of intermenstrual/postcoital bleeding. All previous
smearswere negative and she is a non-smoker. Clinically on examination
there was a 2 × 2.5 cm exophytic lesion on the anterior lip of the cervix.
Biopsy takenwas inconclusive but suggestive of severe cervical glandular
intraepithelial neoplasia (CGIN). The patient was subsequently seen
in colposcopy clinic in December 2008 and a superﬁcial LLETZ (12 ×
10 × 8 mm) was performed which revealed a moderately differentiated
adenocarcinoma of the cervix (10 mmhorizontal width × 5 mmdepth),
incompletely excised, with lymphovascular space invasion (LVSI). The
patientwas then referred to a cancer centrewith the expertise to perform
fertility-sparing surgery.
At the cancer centre review the pathology and MRI of the pelvis
were suggestive of stage 1b1 cervical cancer with a suspicious right
obturator node. An endovaginal MRI pelvis was performed in order to
obtain the following two measurements to determine that the correct
cervical length was excised: the endocervical canal measured 2 cm
and the length from the internal os to the top of the uterine cavity
4.2 cm. At the time of referral the patientwas not pregnant and detailed
counselling of the patient and her partner not only included the stan-
dard treatment but also fertility-sparing surgery. They were warned
about the risks of prematurity but also the need for completion treat-
ment by chemoradiation.
In January 2009 the patient underwent a laparoscopic pelvic lymph-
adenectomy and all 39 nodeswere negative. At that time the pregnancy
test was negative. In February 2009 a radical vaginal trachelectomywas
scheduled but on the morning of her operation the pregnancy test was
positive despite having used condoms for contraception. The ﬁrst day of
her last period was 28/12/08.
The case was re-discussed at the weekly multidisciplinary meeting
and the following options were discussed:
1. Termination of pregnancy would delay the subsequent procedure of
radical vaginal trachelectomy for therewould be a 6 week interval to
allow for healing and resolution of artefact. This would defeat the
purpose of preserving fertility and against the wishes of the couple.
2. Radical vaginal trachelectomy during second trimester. A glandular
tumour with positive margins requires removal of the endocervical
canal in its entirety i.e. up to the isthmus. This is associated with an
increased risk of rupturing membranes and thereby miscarriage at
the time of the procedure. Obstetric advice was sought and by
performing the procedure during the second trimester would mini-
mise the risk of miscarriage associated with the ﬁrst trimester..
Table 1
Radical vaginal trachelectomy during second trimester of pregnancy: summary of literature.
Author Stage Cerclage
in-situ
Complications GA at delivery
(weeks)
Adjuvant therapy Follow-up
(months)
Disease
status
Neonatal outcome/
complications
Van De Nieuwenhof 1b1 Yes No 36 Radical hysterectomy 9 NED Uneventful
Iwami 1b1 Yes No 34 No 14 NED Uneventful
Siouta 1b1 Yes No 37 No 47 NED Uneventful
1b1 Yes No 29 No 30 NED Uneventful
1b1 Yes No 37 No 27 NED Uneventful
Ferriaoli 1b1 Yes No 31 Radical hysterectomy chemoradiation N/A Died of disease Uneventful
GA = gestational age.
NED = no evidence of disease.
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the second trimester to avoid the greater teratogenic risk of treat-
ment in the ﬁrst trimester.
At 16 weeks' gestation a radical vaginal trachelectomy was per-
formed and the specimen measured 40 mm × 40 mm × 38 mm. The
maximum tumour dimension was 32 mm in addition to a tumour
dimension of at least 10 mm in the LLETZ specimen. There was no
evidence of LVSI in the trachelectomy specimen though it was evident
in the LLETZ specimen. The anterior margin was close to the resection
margin. The lateral and distal margins were well clear as was the prox-
imal isthmic margin. By reviewing the reports in order to reconstruct
the cervical cancer and estimate the size of the tumour, the conclusion
reachedwas a diameter of 42 mmThe ﬁnal stagewas stage 1b2moder-
ately differentiated adenocarcinoma of the cervix.
In an attempt to prevent uterine contractions a prophylactic nifedi-
pine patch was administered at the time of the procedure and contin-
ued for a further 24 h. There is a signiﬁcant risk of preterm labour in
this group and an empirical course of erythromycin 250 mg qds was
administered for 10 days and repeated at 24 weeks. Elective steroid
administration was administered at 24 weeks' gestation to accelerate
foetal lung maturity. Bed rest was preferable at home rather than a
prolonged hospital stay between 22 and 26 weeks. At 25 weeks' gesta-
tion she had ruptured her membranes and was admitted to her local
hospital for conservative management withmonitoring of inﬂammato-
ry markers and received a course of antibiotics. The patient was admit-
ted 10 days following rupture of membranes with an antepartum
haemorrhage. However, there was clinical and biochemical evidence
of chorioamnionitis and she underwent an emergency classical caesar-
ean section. A live female infant weighing 830 g was delivered at
26 weeks' gestation with Apgar scores of 6 and 10, at 1 and 5 min,
respectively. Neonatal complications included respiratory distress syn-
drome, chorioamnionitis, and necrotising enterocolitis. The infant was
discharged at a corrected gestational age of 36 weeks weighing 2440 g.
At 3 months postpartum the patient underwent a staging examina-
tion with multiple random biopsies. There was no evidence of disease
recurrence either clinically, radiologically, or histologically. It is now
46 months following primary treatment for cervical cancer and there
is no evidence of recurrence as assessed clinically and radiologically.
Discussion
This case demonstrates radical vaginal trachelectomy as a potential
treatment option in pregnant women with a desire to continue the
pregnancy. It also highlights the clinical dilemma not only for pregnant
young women diagnosed with early stage cervical cancer due to the
risks to the unborn child. The tumour was moderately differentiated
and, although there was LVSI present in the original LLETZ, there was
no evidence in the ﬁnal specimen. There was a good node dissection
of 39 nodes, all negative. The one adverse prognostic factor on the
ﬁnal pathology specimen was the anterior margin being only 1 mm
clear of tumour. In such a situation the treatment option would be
chemoradiation. Postpartum there was the dilemma as to whethercompletion treatment was indicated. In the normal course of events ra-
diotherapy would not be advised until 4–6 weeks after the event, and
given that she was by then nine months after the original diagnosis
with no clinical, radiological, or histological evidence of recurrence, a
surveillance policy has been adopted. It is now 46 months with no evi-
dence of disease recurrence.
In the approach described by Van De Niewenhof et al. 2008 a
cerclage is placed abdominally at the cervico-isthmic junction prior to
proceeding to the vaginal trachelectomy with the vaginal mucosa
approximated to the cervical stump.Wehave always inserted a cerclage
and this is well described in our publications (Shepherd et al., 1998;
Shepherd and Milliken, 2008). We do not advocate a trial without
cerclage. In the histological subtype of adenocarcinomas it is imperative
to ascertain that the whole length of the endocervical canal is removed
up to the isthmus. Therefore the technique described by the former
authors of what appears to be a vagino-cervical anastomosis could po-
tentially result in residual tumour. The difference here is the histological
subtype. In squamous cell carcinoma of the cervix a section of proximal
cervical stromamay be conserved at the isthmus providing an adequate
1 cm clearance is obtained.
In the literature there are two scenarios reported. Ben-Arie et al.,
2004 are advocates of fertility-sparing surgery in pregnant patients
with stage 1a2 cervical cancer. This subgroup can be managed by
knife cone biopsy providing nodes are negative, and this approach
can be adopted in pregnancy (Herod et al., 2010). In an another clin-
ical scenario of stage 1b1, grade 2, adenocarcinoma of the cervix with
lymphovascular invasion diagnosed at 17 weeks' gestational twin
pregnancy, nodal status was assessed laparoscopically. Neoadjuvant
platinum-based chemotherapy was implemented until 32 weeks'
gestation with delivery by elective caesarean section followed imme-
diately by radical hysterectomy (Favero et al., 2010).
There is anecdotal evidence of the use of chemotherapy in more
locally advanced disease. During the 1st trimester the main concern
is congenital malformation, and during the 2nd and 3rd trimesters
low birth weight and intra-uterine growth retardation (Boyd et al.,
2009).
There is an associated 20% risk of preterm labour due to ascending
infection and hence consideration should also be given to prophylactic
use of antibiotics at 16 and 24 weeks' gestation. It is also important
to ensure that during the second half of the pregnancy the patient is
resting and relatively inactive in order tominimise strain on the isthmic
suture. Antenatal care should be in a high risk obstetric unitwith Level 3
neonatal facilities. Mode of delivery is by classical caesarean section.
This case demonstrates thepotential role of radical vaginal trachelec-
tomy in early stage cervical cancer with a favourable outcome tomother
and baby.We do acknowledge a longer follow-up period is required not
only with respect to the mother's prognosis but also the developmental
sequelae associatedwith prematurity. Amultidisciplinary approachwas
imperative in the management of both mother and baby.Conﬂict of interest statement
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